Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNexus Gene Lab (BGLC) Intangibles (2024 - 2025)

BioNexus Gene Lab's Intangibles history spans 2 years, with the latest figure at $450000.0 for Q1 2025.

  • For Q1 2025, Intangibles changed N/A year-over-year to $450000.0; the TTM value through Mar 2025 reached $450000.0, changed N/A, while the annual FY2024 figure was $450000.0, N/A changed from the prior year.
  • Intangibles for Q1 2025 was $450000.0 at BioNexus Gene Lab, roughly flat from $450000.0 in the prior quarter.
  • Across five years, Intangibles topped out at $450000.0 in Q4 2024 and bottomed at $450000.0 in Q4 2024.